Consistent with this, sustained PERK signaling has been shown to enhance neurodegeneration due to acute repression of synaptic proteins, resulting in abnormal neuronal function, as demonstrated through PERK inhibitors in Prion disease (54), frontotemporal dementia (48) and PD models (32). The gene discussed is EIF2AK3; the disease is Parkinson disease.